Meridian Financial’s T2 Biosystems, Inc TTOO Stock Holding History

Meridian Financial’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2	Closed	-$1.13K	–	91
2022 Q3	$1.13K	Hold	2	–	–	﹤0.01%	84
2022 Q2	$1.61K	Buy	+2	New	+$2.96K	﹤0.01%	88

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Meridian Financial's TTOO Position: Q4 2022 in Review

Meridian Financial sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 2 shares — an estimated $1.13K sold.

Meridian Financial first reported a position in TTOO in Q2 2022 and held it in 2 quarters. The position peaked at $1.61K in Q2 2022. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

Meridian Financial reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
Meridian Financial sold 2 T2 Biosystems, Inc shares in Q4 2022, an estimated $1.13K.
Meridian Financial first reported a position in T2 Biosystems, Inc in Q2 2022 and held it in 2 quarters.
Meridian Financial's T2 Biosystems, Inc position peaked at $1.61K in Q2 2022.
20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Meridian Financial's 13F filing for Q4 2022, filed 13 Aug 2024.